Interestingly, although telomerase reverse transcriptase (TERT) promoter mutations did not independently have a statistically significant effect on the recurrence risk and survival of the patients in our cohort, TERT-promoter mutations were identified in 83 % of the primary melanomas. Here, TERT is linked to melanoma.